IBDEI1I5 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24297,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,24297,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,24298,0)
 ;;=E11.649^^82^1051^20
 ;;^UTILITY(U,$J,358.3,24298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24298,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,24298,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,24298,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,24299,0)
 ;;=E11.65^^82^1051^16
 ;;^UTILITY(U,$J,358.3,24299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24299,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,24299,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,24299,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,24300,0)
 ;;=E11.69^^82^1051^31
 ;;^UTILITY(U,$J,358.3,24300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24300,1,3,0)
 ;;=3^DM Type 2 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,24300,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,24300,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,24301,0)
 ;;=E11.8^^82^1051^33
 ;;^UTILITY(U,$J,358.3,24301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24301,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,24301,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,24301,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,24302,0)
 ;;=E11.9^^82^1051^34
 ;;^UTILITY(U,$J,358.3,24302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24302,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,24302,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,24302,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,24303,0)
 ;;=E11.29^^82^1051^26
 ;;^UTILITY(U,$J,358.3,24303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24303,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,24303,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,24303,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,24304,0)
 ;;=E11.311^^82^1051^13
 ;;^UTILITY(U,$J,358.3,24304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24304,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,24304,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,24304,2)
 ;;=E11.319^5002632
 ;;^UTILITY(U,$J,358.3,24305,0)
 ;;=E11.319^^82^1051^14
 ;;^UTILITY(U,$J,358.3,24305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24305,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,24305,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,24305,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,24306,0)
 ;;=E11.3211^^82^1051^21
 ;;^UTILITY(U,$J,358.3,24306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24306,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,24306,1,4,0)
 ;;=4^E11.3211
 ;;^UTILITY(U,$J,358.3,24306,2)
 ;;=^5138331
 ;;^UTILITY(U,$J,358.3,24307,0)
 ;;=E11.3212^^82^1051^22
 ;;^UTILITY(U,$J,358.3,24307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24307,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,24307,1,4,0)
 ;;=4^E11.3212
 ;;^UTILITY(U,$J,358.3,24307,2)
 ;;=^5138332
 ;;^UTILITY(U,$J,358.3,24308,0)
 ;;=E11.3213^^82^1051^23
 ;;^UTILITY(U,$J,358.3,24308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24308,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,24308,1,4,0)
 ;;=4^E11.3213
 ;;^UTILITY(U,$J,358.3,24308,2)
 ;;=^5138333
 ;;^UTILITY(U,$J,358.3,24309,0)
 ;;=E11.40^^82^1051^9
 ;;^UTILITY(U,$J,358.3,24309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24309,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
